A common symptom in advanced cancers is the build-up of fluid in the chest, known as a malignant pleural effusion (MPE), which causes distressing shortness of breath and chest pain. Half of patients with metastatic disease will develop MPE.
SymPhysis Medical are developing a catheter-based technology called RelEase that will be a significantly more effective and patient-centric solution for managing MPE in the home compared to current solutions.
Location: Ireland, Connacht, Galway City
Employees: 1-10
Total raised: $3.68M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 23.07.2023 | Irrus Inve... | irrusinves... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.12.2023 | - | $1.64M | - |
| 25.04.2022 | - | $2.04M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 21.12.2023 | Galway MedTech SymPhysis Medical raises €1.5m for expansion... | Galway-based MedTech company SymPhysis Medical has raised €1.5m in a seed-plus funding round. The f... | businesspl... |
| 25.04.2022 | Angel investors back novel cancer treatment | A novel treatment for cancer patients from SymPhysis Medical has attracted seed funding of €1.9m, wi... | businesspl... |
| 25.04.2022 | Galway-based healthtech startup SymPhysis Medical picks up €... | Driven by a commitment to provide more independence and a better quality of life to patients, SymPhy... | eu-startup... |
| 02.03.2020 | FutureScope One2Watch Finalists Announced | FutureScope organiser Dublin BIC has revealed the five finalists for its One2Watch 2020 competition.... | businesspl... |
| - | SymPhysis Medical | “Home - Symphysis Medical” | fastfounde... |